White paper on the impact of MDR on medical device software
The MDR date of application is imminent. What does it mean for medical device software developers?
18 maj, 2021
Kategori: Information
12 maj, 2021
Rapport om Sveriges kapacitet att producera vaccin
Vinnova har nyligen publicerat en rapport om Sveriges kapacitet att producera vaccin. Rapporten har gjorts tillsammans med RISE på uppdrag av regeringen för att kartlägga hur vår kapacitet står sig i förhållande till omvärlden och presentera vilka synergier som finns mellan produktion av vaccin och biologiska läkemedel.
6 maj, 2021
Voices from NLSDays 2021
Genetic Analysis had over twenty partnering meetings with pharma and investors, and several that are quickly proceeding forward. The company is based in Oslo and was one of the selected NLS Invest Rising Stars. We asked CCO Anita Patel Jusnes to share her experiences of #NLSDays and tell us more about the company.
5 maj, 2021
Kallelse till SwedenBIOs ordinarie föreningsstämma
Den 27 maj kl.16.00–16.30 hålls SwedenBIOs ordinarie föreningsstämma för medlemmarna i digitalt format.
3 maj, 2021
Intervju med Genagon Therapeutics vd Moa Fransson
Inför NLSDays 2021 gjorde DNB en intervju med Genagon Therapeutics vd Moa Fransson. Hon berättar bland annat varför Genagons forskning är viktig, vad som händer i bolaget 2021 och varför NLSDays är en viktig plattform.
22 april, 2021
Highlights from NLSDays Digital, 21st April 2021
Future healthcare is always a key theme at NLSDays and today’s program tackled the complex issue of how to ensure sustainable innovation for the industry, from several different viewpoints.
21 april, 2021
Highlights from NLSDays Digital, 20th April 2021
NLSDays 2021 kicked off with a show of great strength and belief in the industry. Undaunted by the move to a virtual format, presenters and attendees from the Nordics and beyond gathered to consider future-looking solutions for healthcare’s changing and conflicting needs.
20 april, 2021
Apoglyx, Respinor and RetinaRisk Announced as NLSInvest Rising Star Award Winners
Over 150 Nordic companies applied to the launch of the first-ever Nordic Life Science Investment Day, NLSInvest. Following a long review of the applications by a pan-Nordic committee of industry leaders, 80 Rising Stars were ultimately selected to pitch to investors across three dedicated tracks: biotech/pharma, medtech/diagnostics and digital/e-health.
19 april, 2021
NLSDays starting on April 20 – here is the program
Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. Since its inception in 2013, the event has nurtured a community of people from the world of life science, and created a unique place to do business.
16 april, 2021
Ny task force om hållbarhet
Träffa Charlotte af Klercker, Global Director Sustainability and External Affairs på Sobi som leder arbetet.
